Related Experiment Video
Updated: Jun 26, 2026
Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model
Published on: June 20, 2025
Upregulation of macrophage migration inhibitory factor gene expression in stroke
Background And Purpose:
MIF has been implicated to function in many inflammatory processes. This study examined whether MIF expression was affected in stroke and its underlying molecular mechanism.
Methods:
ELISA and qRT-PCR were used to detect MIF protein and mRNA in PBMCs from stroke patients, the ischemic rat brains, and controls. A MIF promoter assay under hypoxia was performed.
Results:
MIF protein and mRNA were significantly increased in stroke patients. Increasing levels of MIF were correlated to the severity of stroke and peaked 24 hours after stroke. MIF was significantly upregulated in focal ischemic rat brains. The activity of the human MIF promoter was significantly increased under hypoxia compared to normoxia.
Conclusions:
MIF gene expression is upregulated after stroke, and hypoxia signaling plays an important role in upregulation of MIF expression under stroke.
Insights
Macrophage migration inhibitory factor (MIF) is upregulated after stroke, correlating with stroke severity. Hypoxia signaling significantly contributes to this increased MIF expression, offering potential therapeutic targets.
Area of Science:
- Neuroscience
- Immunology
- Molecular Biology
Background:
- Macrophage migration inhibitory factor (MIF) is a key mediator in inflammatory processes.
- The role of MIF in the context of stroke pathophysiology remains incompletely understood.
- This study investigates the expression patterns and regulatory mechanisms of MIF following ischemic stroke.
Discussion:
- Elevated MIF levels in peripheral blood mononuclear cells (PBMCs) and ischemic brain tissue suggest its involvement in stroke.
- The correlation between MIF levels and stroke severity highlights its potential as a prognostic biomarker.
- Hypoxia-induced activation of the MIF promoter provides a molecular explanation for its upregulation under ischemic conditions.
Key Insights:
- MIF protein and mRNA levels are significantly elevated in stroke patients and in a rat model of focal cerebral ischemia.
- MIF expression levels correlate with stroke severity and peak within 24 hours post-stroke.
- Hypoxia demonstrably enhances the activity of the MIF promoter, implicating hypoxia signaling in MIF gene regulation.
Outlook:
- Further research into MIF's specific roles in neuroinflammation post-stroke is warranted.
- Targeting MIF or the hypoxia signaling pathway could represent a novel therapeutic strategy for stroke.
- Investigating MIF as a biomarker for stroke progression and outcome is a promising avenue.